Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission
- PMID: 34156977
- PMCID: PMC8410035
- DOI: 10.1172/jci.insight.142073
Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission
Abstract
The majority of patients affected with lysosomal storage disorders (LSD) exhibit neurological symptoms. For mucopolysaccharidosis type IIIC (MPSIIIC), the major burdens are progressive and severe neuropsychiatric problems and dementia, primarily thought to stem from neurodegeneration. Using the MPSIIIC mouse model, we studied whether clinical manifestations preceding massive neurodegeneration arise from synaptic dysfunction. Reduced levels or abnormal distribution of multiple synaptic proteins were revealed in cultured hippocampal and CA1 pyramidal MPSIIIC neurons. These defects were rescued by virus-mediated gene correction. Dendritic spines were reduced in pyramidal neurons of mouse models of MPSIIIC and other (Tay-Sachs, sialidosis) LSD as early as at P10. MPSIIIC neurons also presented alterations in frequency and amplitude of miniature excitatory and inhibitory postsynaptic currents, sparse synaptic vesicles, reduced postsynaptic densities, disorganized microtubule networks, and partially impaired axonal transport of synaptic proteins. Furthermore, postsynaptic densities were reduced in postmortem cortices of human MPS patients, suggesting that the pathology is a common hallmark for neurological LSD. Together, our results demonstrate that lysosomal storage defects cause early alterations in synaptic structure and abnormalities in neurotransmission originating from impaired synaptic vesicular transport, and they suggest that synaptic defects could be targeted to treat behavioral and cognitive defects in neurological LSD patients.
Keywords: Genetics; Lysosomes; Neuroscience; Synapses.
Conflict of interest statement
Figures










Similar articles
-
Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.Dis Model Mech. 2016 Sep 1;9(9):999-1013. doi: 10.1242/dmm.025171. Epub 2016 Aug 4. Dis Model Mech. 2016. PMID: 27491071 Free PMC article.
-
Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression.J Clin Med. 2020 Feb 25;9(3):616. doi: 10.3390/jcm9030616. J Clin Med. 2020. PMID: 32106459 Free PMC article. Review.
-
Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.Eur J Neurosci. 2003 Sep;18(6):1559-71. doi: 10.1046/j.1460-9568.2003.02884.x. Eur J Neurosci. 2003. PMID: 14511335
-
Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease.J Neurosci. 2012 Sep 5;32(36):12312-24. doi: 10.1523/JNEUROSCI.2796-12.2012. J Neurosci. 2012. PMID: 22956822 Free PMC article.
-
Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases.J Inherit Metab Dis. 2017 Sep;40(5):631-640. doi: 10.1007/s10545-017-0048-0. Epub 2017 May 5. J Inherit Metab Dis. 2017. PMID: 28477283 Review.
Cited by
-
Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation.J Clin Invest. 2025 Jun 17;135(16):e177430. doi: 10.1172/JCI177430. eCollection 2025 Aug 15. J Clin Invest. 2025. PMID: 40540388 Free PMC article.
-
Heterologous HSPC Transplantation Rescues Neuroinflammation and Ameliorates Peripheral Manifestations in the Mouse Model of Lysosomal Transmembrane Enzyme Deficiency, MPS IIIC.Cells. 2024 May 20;13(10):877. doi: 10.3390/cells13100877. Cells. 2024. PMID: 38786099 Free PMC article.
-
Effects of Heparan sulfate acetyl-CoA: Alpha-glucosaminide N-acetyltransferase (HGSNAT) inactivation on the structure and function of epithelial and immune cells of the testis and epididymis and sperm parameters in adult mice.PLoS One. 2023 Sep 27;18(9):e0292157. doi: 10.1371/journal.pone.0292157. eCollection 2023. PLoS One. 2023. PMID: 37756356 Free PMC article.
-
Severe central nervous system demyelination in Sanfilippo disease.Front Mol Neurosci. 2023 Dec 13;16:1323449. doi: 10.3389/fnmol.2023.1323449. eCollection 2023. Front Mol Neurosci. 2023. PMID: 38163061 Free PMC article.
-
Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption.JCI Insight. 2023 Oct 23;8(20):e166470. doi: 10.1172/jci.insight.166470. JCI Insight. 2023. PMID: 37698928 Free PMC article.
References
-
- Scriver CR, et al. The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Professional; 2001.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous